<DOC>
	<DOCNO>NCT01587235</DOCNO>
	<brief_summary>This study evaluate compare effectiveness MK-0653 ( Vytorin ) current standard treatment statins treatment dyslipidemia moderate , moderately-high high-risk participant .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Vytorin Versus Standard Treatment Other Statins Moderate , Moderately High High Risk Participants ( MK-0653A-406 )</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Lowdensity lipoprotein cholesterol ( LDLC ) ≥100 mg/dL Either treatment naïve ( previous treatment lipidlowering medication ) previously treat lipidlowering medication , must complete washout 6 week prior enrollment LDLC level ≥ 190 mg/dL Hypersensitivity intolerance Vytorin , ezetimibe simvastatin Taking lipid lower agent except statin . ( i.e . fenofibrate , niacin , ezetimibe , etc ) Pregnant breastfeeding , expect conceive within project duration study Currently participate previously participate study within 30 day Congestive heart failure define New York Heart Association ( NYHA ) Class III IV within previous 6 month Uncontrolled cardiac arrhythmia recent significant electrocardiogram ( ECG ) change Unstable angina pectoris Myocardial infarction , coronary artery bypass surgery , angioplasty within previous 3 month Unstable severe peripheral artery disease within previous 3 month Uncontrolled hypertension ( treat untreated ) Type 1 Type 2 diabetes mellitus poorly control recently diagnose ( within previous 3 month ) Uncontrolled endocrine metabolic disease know influence serum lipid lipoproteins Serious cerebrovascular disorder ( ischemic stroke cerebral hemorrhage ) within previous 6 month Received treatment systemic corticosteroid , cyclical hormone within previous 8 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>